AstraZeneca Transfers Valeant's European Rights To Troubled Drug
July 01, 2016 at 09:58 AM EDT
Psoriasis drug brodalumab, which Amgen abandoned after suicide reports, will now be marketed in Europe by LEO Pharma.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.